David Linetsky Phreesia, Inc. (PHR) insider trading activity

David Linetsky is SVP, Life Sciences of Phreesia, Inc.. Currently has a direct ownership of 239,211 shares of PHR, which is worth approximately $6.38 Million. The most recent transaction as insider was on Jan 15, 2023, when has been sold 45,184 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 239K

17.65% 3M change

0.92% 12M change

Total Value Held $6.38 Million

David Linetsky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2023	BUY Grant, award, or other acquisition	-	45,184 Added 17.18%	217,831 Common Stock
Jan 14 2023	SELL Payment of exercise price or tax liability	$56,372 $35.41 p/Share	1,592 Reduced 0.86%	183,893 Common Stock
Dec 13 2022	SELL Open market or private sale	$393,757 $34.61 p/Share	11,377 Reduced 5.78%	185,485 Common Stock
Dec 09 2022	SELL Open market or private sale	$798,937 $29.77 p/Share	26,837 Reduced 12.0%	196,862 Common Stock
Oct 14 2022	SELL Payment of exercise price or tax liability	$39,318 $22.48 p/Share	1,749 Reduced 0.78%	223,699 Common Stock
Sep 12 2022	SELL Payment of exercise price or tax liability	$18,273 $29.19 p/Share	626 Reduced 0.28%	225,448 Common Stock
Sep 12 2022	BUY Grant, award, or other acquisition	-	1,589 Added 0.7%	226,074 Common Stock
Jul 14 2022	SELL Payment of exercise price or tax liability	$29,390 $22.35 p/Share	1,315 Reduced 0.58%	224,485 Common Stock
Apr 14 2022	SELL Payment of exercise price or tax liability	$36,333 $27.63 p/Share	1,315 Reduced 0.58%	225,800 Common Stock
Apr 13 2022	SELL Payment of exercise price or tax liability	$64,757 $28.73 p/Share	2,254 Reduced 0.98%	227,115 Common Stock
Apr 13 2022	BUY Grant, award, or other acquisition	-	9,253 Added 3.88%	229,369 Common Stock
Jan 17 2022	SELL Payment of exercise price or tax liability	$14,789 $35.55 p/Share	416 Reduced 0.19%	220,116 Common Stock
Jan 15 2022	SELL Payment of exercise price or tax liability	$151,123 $35.55 p/Share	4,251 Reduced 1.89%	220,532 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	53,445 Added 19.21%	224,783 Common Stock
Jan 06 2022	BUY Exercise of conversion of derivative security	$180,129 $5.82 p/Share	30,950 Added 15.3%	171,338 Common Stock
Nov 08 2021	SELL Open market or private sale	$112,605 $75.12 p/Share	1,499 Reduced 1.06%	140,388 Common Stock
Nov 08 2021	BUY Exercise of conversion of derivative security	$7,060 $4.71 p/Share	1,499 Added 1.05%	141,887 Common Stock
Nov 05 2021	SELL Open market or private sale	$261,372 $75.15 p/Share	3,478 Reduced 2.42%	140,388 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$16,381 $4.71 p/Share	3,478 Added 2.36%	143,866 Common Stock
Nov 01 2021	SELL Open market or private sale	$386,094 $70.83 p/Share	5,451 Reduced 3.74%	140,388 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$25,674 $4.71 p/Share	5,451 Added 3.6%	145,839 Common Stock
Oct 15 2021	SELL Open market or private sale	$356,343 $65.36 p/Share	5,452 Reduced 3.74%	140,388 Common Stock
Oct 15 2021	BUY Exercise of conversion of derivative security	$25,679 $4.71 p/Share	5,452 Added 3.6%	145,840 Common Stock
Sep 01 2021	SELL Open market or private sale	$351,248 $70.56 p/Share	4,978 Reduced 3.42%	140,388 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$23,446 $4.71 p/Share	4,978 Added 3.31%	145,366 Common Stock

David Linetsky

SVP, Life Sciences

Raleigh, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Value

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Phreesia, Inc.

Track Activities on PHR

Account